6 research outputs found
Effects of nitrous oxide sedation on sympathetic batireflex sesensitivity.
ç¬æ°åžå
¥é®éæ³ïŒISïŒã¯äžå®ïŒææå¿ã®åŒ·ãæ£è
ïŒç¥çé害è
ïŒå
éšé害çãæããæ£è
ãªã©ã«å¿çšããã粟ç¥é®éæ³ã§ããïŒåèå§ã¯å§å容åšåå°ã«ããç¶æã»èª¿æŽãããŠãããïŒäºé
žåçªçŽ ïŒN2OïŒåžå
¥ãå§å容åšåå°æåæ§ïŒBRSïŒã«åœ±é¿ãããã¯äžæã§ããïŒããã§ïŒISäžã«é£ç¶è¡å§ãšïŒãã€ã¯ããã¥ãŒãã°ã©ãã£ãŒãçšããŠç亀æç¥çµæŽ»åïŒMuscle Sympathetic Nerve ActivityïŒMSNAïŒãåæ枬å®ãïŒåèå§ã®å€åã«å¯Ÿããæ«æ¢¢è¡ç®¡èª¿ç¯æ§äº€æç¥çµæŽ»åã®å€åéããBRSãæ€èšŒããïŒå¥åžžæ人ç·æ§10å31±2æ³ïŒœã察象ã«ïŒæ°Žå¹³ä»°è¥äœã§ã«ãŒã ãšã¢ãŒïŒ100ïŒ
é
žçŽ ïŒO2ïŒïŒ30ïŒ
N2OïŒ40ïŒ
N2Oããããã20åéåžå
¥ããåŸïŒåæ¡ä»¶äžã§å¿ææ°ïŒHRïŒïŒå¿æåºéïŒCOïŒïŒ1åæåºéïŒSVïŒïŒé£ç¶è¡å§ããã³MSNAã5åé枬å®ããïŒããã«ïŒO2ã20åéåžå
¥ããåŸã«å埩æãèšãïŒã«ãŒã ãšã¢ãŒã§5åéåæ§ã®æž¬å®ãããïŒBRSã®è©äŸ¡ã®ããã«ïŒãŸãïŒé£ç¶è¡å§ã®æ¡åŒµæè¡å§ïŒDBPïŒã3mmHgããšã«ã°ã«ãŒãã³ã°ãè¡ãïŒåã°ã«ãŒãã®DBPå¹³åå€ãDBPã®ä»£è¡šå€ãšãïŒ100æãããã®MSNAã®ããŒã¹ãæ°ïŒBIïŒãšããŒã¹ãé¢ç©ïŒTotal MSNAïŒãMSNA代衚å€ãšããïŒåã°ã«ãŒãã®DBPãšBIããã³Total MSNA代衚å€ããæ±ããçŽç·ååž°ã®åŸãã亀æç¥çµæ§å§å容åšåå°æåæ§ïŒsBRSïŒãšããïŒåISæ¡ä»¶éã§HRïŒCOïŒè¡å§ã«å·®ã¯ãªãã£ãïŒãŸãïŒDBPãšBIããã³Total MSNAã§æ±ããsBRSã¯äž¡è
ãšãISæ¿åºŠã«ããå€åã瀺ããªãã£ãïŒä»¥äžããïŒç¬æ°åžå
¥äžã«å§å容åšåå°ã®ãªãã¬ãŒãã£ã³ã°ãã€ã³ãïŒæåæ§ãšãç¶æãããããšã瀺åãããïŒ2019å士ïŒæ¯åŠïŒæŸæ¬æ¯ç§å€§
å¯ãã磚ãã«å¯Ÿãã幌å ã®é©å¿æ§
å¥åžžãªå¹Œå
ã®å¯ãã磚ãã«å¯Ÿããé©å¿æ§ãšçºé幎霢,æŠå¹Žéœ¢ãšã®é¢é£æ§ãæããã«ããããã«,ä¿è·è
ã«å¯ãã磚ãããã,ãã®ç¶æ
ã芳å¯ãããšãšãã«VTRã«ãŠèšé²ã,AICã«åºã¥ã解æãè¡ã£ã.調æ»å¯Ÿè±¡è
ã¯,å¥åžžãªå¹Œå
98åã§ãã.çºéæ€æ»ã¯é å寺åŒä¹³å¹Œå
åæççºéæ€æ»ãå®æœãã.çµæã¯ä»¥äžã®éãã§ãã.1.æ¯ç£šãä»å©(ä»äžã磚ããå«ã)ã1æ¥1å以äžè¡ã£ãŠããä¿è·è
ã¯,89.8%ã§ãã£ã.2.å¯ãã磚ãã®éã«,芳å¯ããã幌å
ã®äžé©å¿è¡åã®ãã¡,æãå€ãã£ãã®ã¯ãæãåºããŠéªéããã(20.4%)ãã§ãã£ã.以äž,ãé ãåãã(17.3%)ã,ãäœäœãå€ãã(17.3%)ã,ãå£ãéãã(15.3%)ã,ãæ¯ãã©ã·ããã(13.3%)ã,ãæ³£ã(13.3%)ãã®é ã§ãã£ã.3.å¯ãã磚ãã«é©å¿ããè
ã¯78.6%ã§,äžé©å¿ã§ãã£ãè
ã¯21.4%ã§ãã£ã.4.å¯ãã磚ãã®éã«,åäŸãæå¶ããä¿è·è
ã¯,12.2%èªããã,ä»ã®87.8%ã¯æå¶ããªãã£ã.åäŸãæåŠè¡åã瀺ããã«ãããããã,æå¶ããªãã£ãä¿è·è
ã¯9.2%ãã.5.å¯ãã磚ãã®é©å¿æ§ãšçºé幎霢,æŠå¹Žéœ¢ãšã¯,匷ãé¢é£æ§ãèªãããã.6.å¯ãã磚ãã®é©å¿ã»äžé©å¿ãå€å¥ã§ããæé©ãªã«ããŽãªãŒã¯,é å寺åŒä¹³å¹Œå
åæççºéæ€æ»é
ç®ã®ãããã2æ³6ã«æååŸã§ãã£ã.7.æŠå¹Žéœ¢2æ³6ã«æ以äžã§ããã°,å¯ãã磚ãã«é©å¿ã§ããã¬ãã£ãã¹ãåãã£ãŠããããšãæãããšãªã£ã
å¿èº«é害å ã®ãã©ãã·ã³ã°ã«é¢ããç 究第1å ± ãã©ãã·ã³ã°ãšçºé段éãšã®é¢é£
æœèšåšç±ã®å¿èº«é害å
146åã«ã€ããŠ,å£è
æž
æç¶æ³,ãã©ãã·ã³ã°è¡å,çºé段éãªã©ã調æ»ã,次ã®ãããªçµæãåŸãã1)ãã©ãã·ã³ã°ã¯å
šå¡ã«è¡ãããŠããã,93.2%ã®è
ã¯ãªãããã®åœ¢ã§,ä¿è·è
ã»è·å¡ã®é¢äžãåããŠããã2)67.8%ã®è
ãå£è
æž
æç¶æ
ã¯è¯å¥œãŸãã¯ããããè¯å¥œãšå€å®ããããããã¯ä¿è·è
ã»è·å¡ã®ç©æ¥µçãªé¢äžã«ãããšããã倧ãããšèããããã3)ãã©ãã·ã³ã°è¡åãšåçºéåéãšã®éã«ããããŠé«ãçžé¢ãèªãããããæãé¢é£æ§ã®åŒ·ãã£ãçºéåéã¯,粟ç¥çºéé
æ»å
ãšèªéçå
ã§ã¯åºæ¬çç¿æ
£,éåé害+粟ç¥çºéé
æ»å
ã§ã¯èšèªç解ã§ãã£ãã4)粟ç¥çºéé
æ»å
ãšèªéçå
ã§ã¯,åºæ¬çç¿æ
£ã3æ³6ã«æã¬ãã«ä»¥äžã®çºéã瀺ããœ,æ¯ãã©ã·ã䜿ã,4æ³ã¬ãã«ä»¥äžã§ããã°,èªç«ã®å¯èœæ§ããããšèªããããã5)éåé害+粟ç¥çºéé
æ»å
ã§ã¯,èšèªç解ã®çºéã2æ³ã¬ãã«ä»¥äžã瀺ãã°,ãã©ãã·ã³ã°ãç解ã§ã,3æ³6ã«æã¬ãã«ä»¥äžã§ããã°,æ¯ãã©ã·ãæ瀺ããããšãããžå±ããããšãå¯èœã«ãªãããšãèªããããã6)ãã©ãã·ã³ã°è¡åã®çºéã«ã¯,äžå®ã®ã¬ãã£ãã¹ãèæ
®ããããšãéèŠã§ãããšèãããã
å¿èº«é害å ã®ãã©ãã·ã³ã°ã«é¢ããç 究
åŠç¿çè«ã«åºã¥ããŠèè
ããéçºãããã©ãã·ã³ã°æå°æ³ãçšããŠ,éåé害ãå䜵ããŠããªãçºéé害è
53åã察象ã«å»¶ã¹165å(1人平å3.1å)ã®æå°ãè¡ã,ãã®çµæã«ã€ããŠåæãã.1.æå°ãç¹°ãè¿ãã«ãããã£ãŠ,å¹³åOHI-Sãäœäžã,ä¿è·è
ã®æèãæ¹åãããããšãèªãããã.2.ç¶ç¶çã«æå°ã,ãã©ãã·ã³ã°è¡åã®å€å®¹ãè©Šã¿ãçµæ,ãã©ãã·ã³ã°ã»ã¹ã³ã¢ã«ããè©äŸ¡ã«ãããŠã¯,50.9%ã®è
ã«äžéãèªãããã.3.ãã©ãã·ã³ã°ã»ã¬ãã«ã§è¡åå€å®¹ã®ç¶æ
ãæ€èšãããšãã,æå°åŸã¯,ãå
šäœçã«ç£šãããè
ã9.4%ãã28.3%ãžãšèããå¢å ãã.4.é å寺åŒä¹³å¹Œå
åæççºéæ€æ»ã«ãããåºæ¬çç¿æ
£ã®çºé幎霢ã3æ³æªæºã®è
ã¯,æ°ããªèª²é¡ã®èªç¥ãå°é£ã§ããã,3æ³ä»¥äžã«ãªããšèªç¥ã§ããåŸåãèªãããã.5.æå°æã«èªç¥ã§ããªã課é¡ã¯,ç¿æ
£ãšããŠã¯å®çãã,æå°ãšããŠäŸ¡å€ã®ãªãããšã瀺åããã.6.éšåçã«ç£šãèœåã®ãã3æ³ã¬ãã«ä»¥äžã®è
ã«ã¯,é«ãæå°å¹æãèªãããã.7.ã¬ãã£ãã¹ãè©äŸ¡ã,ããã°ã©ã åŠç¿ã«åºã¥ãããã©ãã·ã³ã°æå°ã¯,åã
ã®çºé段éãšãã©ãã·ã³ã°ã»ã¬ãã«ã«å¿ããå¹æçãªæå°ãã§ã,ããããŠæçšã§ãããšèãã
å 倩æ§èµ€èœçç(Josephs-Blackfan-Diamond type) ã®ãã,å¯è ç®è³ªãã«ã¢ã³å€ãé·ææçšããŠããå ç«äžå šçå矀ã®äžäŸ
å
倩æ§èµ€èœçç(Josephs-Blackfan-Diamond type) ãšå
ç«äžå
šçå矀ãšãå䜵ããããããŠçšãªçäŸã«å¯ŸããŠ,露èæ²»çãšãã®åŸã®æ¯ç§çå¥åº·ç®¡çãè¡ã£ããå蚺æã¯8æ³ã§,çåŸ3ãµæ以é,çŸåšãŸã§åãç®ãªãå¯è
ç®è³ªãã«ã¢ã³å€ãæçšããŠãã,粟ç¥çºéé
æ»ãšèããçºè²é害ãèªããããã液è¡æ¶²æ€æ»ã§ã¯, è¡è²çŽ é1 3. 6 g / d l , ãããã¯ãªãã4 1 % ã§, 貧è¡ç¶æ
ã¯æ¹åãããŠããã, å
ç«ã°ãããªã³ã¯å
šã¯ã©ã¹ãšã枬å®å¯èœéãèªããªãã£ããO K T 3 ã¯9 0 % , O K T 4ã¯35.4%,OKT8ã¯52.2%ã§,cytotoxic/suppressor T cellãåªäœã§ãã£ããå蚺æã®äž»èšŽã¯,äžé¡å³åŽç¬¬äžå€§èŒæ¯ã®ææã«èµ·å ããèªçºçã§,ä»ã«ãæ²»çãèŠãã露èã6æ¯ãã£ããå£è
æž
æç¶æ
ã¯äžè¯ã§ãã£ãã,æ¯èããã³å£è
ç²èã«ã¯èããç
å€ã¯èªããããªãã£ãã粟ç¥çºéé
æ»ã«ããäžååãèããã£ãã®ã§,å
šèº«éº»é
äžã«ãŠéœ²èæ²»çãè¡ã£ãããã®åŸã¯,ãªã³ãŒã«ã»ã·ã¹ãã ã«ããæ¯ç§çå¥åº·ç®¡çãè¡ã,è¯å¥œãªçµéãã¿ãŠããã1幎5ãµæåŸ(9æ³10ãµæ)ã®åŽè²é éšXç·èŠæ Œåçã§ã¯,äžäžé¡åæ¯ã®æ¯è»žåŸæã«é¢ããŠã¯,ç°åžžãèªããããªãã£ãã,éªšæ Œçã«ã¯äžäžé¡ã®å£æé·ãèªãããããæããã³ææ ¹éªšXç·åçã§ã¯,骚æç床ã®èããé
ããèªããã1幎8ãµæåŸ(10æ³1ãµæ)ã«è¡ã£ãæš¡ååæã®çµæ,äžäžé¡ãšãæ¯ååŒå¹
åŸã¯å°ããå€ã瀺ããŠãããäžäžé¡ã®å£æé·ãšéªšæç床ã®é
延ã«ã¯,å¯è
ç®è³ªãã«ã¢ã³å€ã®å¯äœçšãé¢äžããŠãããã®ãšèãããã
æ¯ç§ç管ç5幎åŸã®éçå¿èº«é害è ã®å£è å æèŠ
éçå¿èº«é害è
ã«å¯Ÿããé©åãªæ¯ç§çå¥åº·ç®¡çã®ç¢ºç«ãç®çãšã,åœç«çé€æã«å
¥é¢äžã®éçå¿èº«é害è
140åã«ã€ããŠ,æ¯ç§ç管çã5幎éã«ããã£ãŠè¡ã£ãåŸã®ç¿»èãšæ¯åšçŸæ£ã«ã€ããŠèª¿æ»ãè¡ã£ã.1.å
šé¢ä»å©ã«ãã1æ¥2åã®ãã©ãã·ã³ã°ãç¿æ
£åãããŠãã.ä»å©ããæã®è·å¡ã®ãã©ãã·ã³ã°æ¹æ³ã¯,64.3%ã暪磚ãã§ãã£ã.2.ä»å©ã«ãããã©ãã·ã³ã°ã«ããããé©å¿ããŠããè
ã¯85.0%ã§ãã£ã.ããã2.1%ã®è
ã¯,ã²ã©ãå«ãã£ãŠåæ¯ã磚ãããªãã£ã.3.å¹³åOHI-Sã¯1.53ã§,éšäœå¥ã«æž
æç¶æ
ãã¿ããš,äžé¡åæ¯éšåé¢ãæãè¯ã,äžé¡å·ŠåŽèŒæ¯éšèé¢ãæãäžè¯ã§ãã£ã.4.1人平åDMFæ¯æ°ã¯,12.51æ¯,DMFæ¯ç48.2%ã§ãã£ã.ãã®ãã¡1人平åã®æªåŠçœ®éœ²èæ¯ã¯,2.07æ¯ã§ãã,æ¯ç§æ²»çäœå¶ãå«ãæ¯ç§çå¥åº·ç®¡çã®ç¢ºç«ã«ãã£ãŠ,露èã®åé¡ã¯ã»ãŒè§£æ±ºã§ããŠãããšæããã.5.æ¯èå¢æ®ã»è¥å€§ã¯,19.3%ã®è
ã«èªãããã.ãã®ãã¡ãã§ããã€ã³æçšè
ã®æ¯èå¢æ®çºçŸçã¯,38.5%ã§ãã£ã.6.éå±åæ¯èéçž®ã¯,10.7%ã®è
ã«èªããã,äžé¡åæ¯éšååŽæ¯èã«æãå€ã,ä»å©è
ã®æšªç£šããšã®é¢é£ã瀺åããã.7.æ¯åšæ²»çã®èŠæ±åºŠ(CPITN)ãã¿ããš,å
šãæ¯åšæ²»çã®å¿
èŠã®ãªãè
ã¯10.8%ã§,ãªãããã®æ²»çãå¿
èŠãšãªãè
ã¯89.2%ã§ãã£ã